LEPTOS BIOMEDICAL INC has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets medical technology and pharmaceuticals are BIOPHORETIC THERAPEUTIC SYSTEM, MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST and GALVANI LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dobak John D | 9 |
#2 | Neisz Hans | 6 |
#3 | Dobak Iii John D | 4 |
#4 | Narciso Jr Hugh Louis | 1 |
#5 | Maniak Jeremy | 1 |
#6 | Narciso Hugh Louis Jr | 1 |
#7 | Cardinal Ralph | 1 |
#8 | Iki Kobi | 1 |
#9 | Skubitz Jason John | 1 |
#10 | Dobak John D Iii | 1 |
Publication | Filing date | Title |
---|---|---|
US2010168820A1 | Automatic threshold assesment utilizing patient feedback | |
WO2009020581A1 | Efferent and afferent splanchnic nerve stimulation | |
EP2106275A2 | Dynamic nerve stimulation employing frequency modulation | |
US2007203521A1 | Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes | |
US2006190053A1 | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes | |
US2006079943A1 | Devices and methods for gynecologic hormone modulation in mammals | |
US7689276B2 | Dynamic nerve stimulation for treatment of disorders | |
US7551964B2 | Splanchnic nerve stimulation for treatment of obesity | |
US7236822B2 | Wireless electric modulation of sympathetic nervous system | |
US7239912B2 | Electric modulation of sympathetic nervous system |